Tarsa releases positive results from osteoporosis drug Phase III trial
The Phase III multinational, randomized, double-blind, double-dummy, placebo-controlled trial enrolled 565 postmenopausal women with established osteoporosis in six countries. The study’s primary endpoint was the percent change in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.